Victory Capital Management Inc Corcept Therapeutics Inc Transaction History

Victory Capital Management Inc

  • $95.7 Billion
  • Q4 2024

A detailed history of Victory Capital Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 75,029 shares of CORT stock, worth $4.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,029
Previous 41,823 79.4%
Holding current value
$4.77 Million
Previous $1.93 Million 95.45%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$44.66 - $60.85 $1.48 Million - $2.02 Million
33,206 Added 79.4%
75,029 $3.78 Million
Q3 2024

Nov 05, 2024
BUY
$29.51 - $46.26 $406,854 - $637,786
13,787 Added 49.18%
41,823 $1.93 Million
Q2 2024

Aug 05, 2024
SELL
$22.21 - $34.48 $151,250 - $234,808
-6,810 Reduced 19.54%
28,036 $910,000
Q1 2024

May 03, 2024
SELL
$21.1 - $27.46 $250,773 - $326,362
-11,885 Reduced 25.43%
34,846 $877,000
Q4 2023

Feb 05, 2024
SELL
$24.82 - $32.88 $803,125 - $1.06 Million
-32,358 Reduced 40.91%
46,731 $1.52 Million
Q3 2023

Nov 06, 2023
SELL
$21.97 - $33.8 $2.19 Million - $3.38 Million
-99,896 Reduced 55.81%
79,089 $2.16 Million
Q2 2023

Jul 27, 2023
SELL
$21.44 - $25.15 $50,276 - $58,976
-2,345 Reduced 1.29%
178,985 $3.98 Million
Q1 2023

May 02, 2023
BUY
$19.2 - $24.47 $91,084 - $116,085
4,744 Added 2.69%
181,330 $3.93 Million
Q4 2022

Feb 10, 2023
BUY
$19.95 - $29.96 $104,617 - $157,110
5,244 Added 3.06%
176,586 $3.59 Million
Q4 2022

Feb 09, 2023
BUY
$19.95 - $29.96 $987,884 - $1.48 Million
49,518 Added 40.65%
171,342 $3.48 Million
Q3 2022

Nov 02, 2022
SELL
$24.7 - $29.12 $115,200 - $135,815
-4,664 Reduced 3.69%
121,824 $3.12 Million
Q2 2022

Aug 01, 2022
SELL
$17.33 - $25.3 $96,736 - $141,224
-5,582 Reduced 4.23%
126,488 $3.01 Million
Q1 2022

May 04, 2022
SELL
$16.53 - $25.21 $35,522 - $54,176
-2,149 Reduced 1.6%
132,070 $2.91 Million
Q4 2021

Feb 07, 2022
BUY
$17.1 - $23.34 $56,874 - $77,628
3,326 Added 2.54%
134,219 $2.66 Million
Q3 2021

Nov 02, 2021
BUY
$19.68 - $22.53 $1.52 Million - $1.74 Million
77,404 Added 144.71%
130,893 $2.58 Million
Q2 2021

Aug 03, 2021
BUY
$19.97 - $24.43 $41,797 - $51,131
2,093 Added 4.07%
53,489 $1.18 Million
Q1 2021

May 04, 2021
SELL
$23.49 - $30.56 $435,034 - $565,971
-18,520 Reduced 26.49%
51,396 $1.22 Million
Q4 2020

Feb 01, 2021
SELL
$16.78 - $27.3 $796,664 - $1.3 Million
-47,477 Reduced 40.44%
69,916 $1.83 Million
Q3 2020

Nov 09, 2020
BUY
$12.46 - $19.98 $11,762 - $18,861
944 Added 0.81%
117,393 $2.04 Million
Q2 2020

Aug 07, 2020
BUY
$11.0 - $18.26 $410,949 - $682,175
37,359 Added 47.24%
116,449 $1.96 Million
Q1 2020

May 04, 2020
BUY
$10.11 - $14.04 $119,874 - $166,472
11,857 Added 17.64%
79,090 $940,000
Q4 2019

Feb 06, 2020
BUY
$12.06 - $16.96 $9,853 - $13,856
817 Added 1.23%
67,233 $814,000
Q4 2019

Feb 04, 2020
BUY
$12.06 - $16.96 $88,387 - $124,299
7,329 Added 12.4%
66,416 $841,000
Q3 2019

Nov 12, 2019
BUY
$10.41 - $14.66 $567,855 - $799,688
54,549 Added 1202.05%
59,087 $835,000
Q2 2019

Aug 15, 2019
SELL
$9.78 - $12.76 $77,095 - $100,587
-7,883 Reduced 63.47%
4,538 $51,000
Q1 2019

May 03, 2019
SELL
$10.03 - $15.71 $68,555 - $107,377
-6,835 Reduced 35.5%
12,421 $146,000
Q4 2018

Feb 05, 2019
BUY
$11.29 - $17.19 $8,490 - $12,926
752 Added 4.06%
19,256 $257,000
Q3 2018

Nov 01, 2018
BUY
$12.27 - $15.65 $115,534 - $147,360
9,416 Added 103.61%
18,504 $259,000
Q2 2018

Aug 02, 2018
BUY
$15.3 - $19.69 $19,079 - $24,553
1,247 Added 15.9%
9,088 $143,000
Q1 2018

May 04, 2018
BUY
$14.59 - $25.5 $25,167 - $43,987
1,725 Added 28.2%
7,841 $129,000
Q4 2017

Feb 01, 2018
BUY
$15.77 - $20.72 $8,389 - $11,023
532 Added 9.53%
6,116 $110,000
Q3 2017

Oct 27, 2017
BUY
$12.3 - $19.3 $68,683 - $107,771
5,584
5,584 $108,000

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email